A Case-Control Study to Assess Procalcitonin Serum Levels in Children Under the Age of Five with UTI
暂无分享,去创建一个
[1] T. Waterfield,et al. Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study , 2018, BMC Pediatrics.
[2] A. Van den Bruel,et al. Point-of-care C reactive protein to identify serious infection in acutely ill children presenting to hospital: prospective cohort study , 2017, Archives of Disease in Childhood.
[3] E. Chiappini,et al. Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: a systematic review and meta-analysis , 2017, Expert review of anti-infective therapy.
[4] P. Póvoa,et al. Use of biomarkers in pediatric sepsis: literature review , 2016, Revista Brasileira de terapia intensiva.
[5] A. Gervaix,et al. Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants , 2016, Pediatrics.
[6] S. Aronoff,et al. Use of serum procalcitonin in evaluation of febrile infants: a meta-analysis of 2317 patients. , 2014, The Journal of emergency medicine.
[7] H. Otukesh,et al. Serum procalcitonin level for prediction of high-grade vesicoureteral reflux in urinary tract infection. , 2014, Iranian journal of kidney diseases.
[8] P. Mahajan,et al. Evaluation of child with fever without source: review of literature and update. , 2013, Pediatric clinics of North America.
[9] K. Lue,et al. Role of Procalcitonin in Predicting Dilating Vesicoureteral Reflux in Young Children Hospitalized With a First Febrile Urinary Tract Infection , 2013, The Pediatric infectious disease journal.
[10] Chien-Chang Lee,et al. Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. , 2012, Annals of emergency medicine.
[11] G. Breart,et al. Prediction of High-Grade Vesicoureteral Reflux after Pediatric Urinary Tract Infection: External Validation Study of Procalcitonin-Based Decision Rule , 2011, PloS one.
[12] K. Lue,et al. The role of procalcitonin for acute pyelonephritis and subsequent renal scarring in infants and young children. , 2011, The Journal of urology.
[13] A. Gervaix,et al. Procalcitonin: A Key Marker in Children with Urinary Tract Infection , 2011, Advances in urology.
[14] Frank Buntinx,et al. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review , 2010, The Lancet.
[15] D. Gendrel,et al. [Procalcitonin and prediction of vesico-ureteral reflux in pediatric urinary tract infection]. , 2007, Bulletin de l'Académie Nationale de Médecine.
[16] G. Breart,et al. Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection. , 2006, Pediatrics.
[17] C. Byington,et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. , 2004, Pediatrics.
[18] J. Šimák,et al. [Procalcitonin--a marker of systemic infection and multiorgan dysfunction: characteristics of the gene and protein]. , 2001, Ceskoslovenska fysiologie.
[19] J. Bouyer,et al. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants. , 2016, JAMA pediatrics.
[20] A. Ghafari,et al. Diagnostic Values of Serum Procalcitonin in Kidney Diseases , 2015 .
[21] J. Judge. FEVER IN THE PEDIATRIC PATIENT. , 1965, The Journal of the American Osteopathic Association.